SMO and skin basal cell carcinoma: Having shown a pronounced inhibitory effect of 4SC‐202 on HH/GLI signaling and proliferation downstream of SMO, we next investigated whether 4SC‐202 treatment can repress the in vivo growth of HH/GLI dependent BCC cells in a preclinical in vivo model.